3KCF

Crystal structure of TGFbRI complexed with a pyrazolone inhibitor

Summary for 3KCF

Entry DOI	10.2210/pdb3kcf/pdb
Descriptor	TGF-beta receptor type-1, 4-[3-(methoxymethyl)phenyl]-1,2-dimethyl-5-quinoxalin-6-yl-1,2-dihydro-3H-pyrazol-3-one, PHOSPHATE ION, ... (4 entities in total)
Functional Keywords	kinase, tgfbetari, structure-based drug design, protein-inhibitor complex, aortic aneurysm, atp-binding, craniosynostosis, disease mutation, disulfide bond, glycoprotein, magnesium, manganese, membrane, metal-binding, nucleotide-binding, phosphoprotein, polymorphism, receptor, serine/threonine-protein kinase, transferase, transmembrane
Biological source	Homo sapiens (human)
Cellular location	Membrane; Single-pass type I membrane protein: P36897
Total number of polymer chains	5
Total formula weight	197639.87
Authors	Boriack-Sjodin, P.A. (deposition date: 2009-10-21, release date: 2009-12-22, Last modification date: 2024-04-03)
Primary citation	Guckian, K.,Carter, M.B.,Lin, E.Y.,Choi, M.,Sun, L.,Boriack-Sjodin, P.A.,Chuaqui, C.,Lane, B.,Cheung, K.,Ling, L.,Lee, W.C. Pyrazolone based TGFbetaR1 kinase inhibitors. Bioorg.Med.Chem.Lett., 20:326-329, 2010 Cited by PubMed: 19914068 DOI: 10.1016/j.bmcl.2009.10.108 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (2.8 Å)

Structure validation